NASDAQ:UTMD Utah Medical Products - UTMD Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Utah Medical Products, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $92.77 -0.14 (-0.15%) (As of 03/27/2023 12:00 AM ET) Add Compare Share Share Today's Range$90.61▼$93.9850-Day Range$87.14▼$96.4752-Week Range$80.10▼$109.50Volume2,988 shsAverage Volume11,084 shsMarket Capitalization$336.76 millionP/E Ratio20.57Dividend Yield1.27%Price TargetN/A ProfileChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability Utah Medical Products MarketRank™ ForecastAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.96% of Float Sold ShortDividend StrengthWeakBased on Four FactorsSustainability-0.92Upright™ Environmental ScoreNews Sentiment1.23Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.26 out of 5 starsMedical Sector254th out of 995 stocksSurgical & Medical Instruments Industry21st out of 103 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Utah Medical Products. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.96% of the float of Utah Medical Products has been sold short.Short Interest Ratio / Days to CoverUtah Medical Products has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Utah Medical Products has recently increased by 22.56%, indicating that investor sentiment is decreasing significantly. Previous Next 1.7 Dividend Strength Dividend YieldUtah Medical Products pays a meaningful dividend of 1.27%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthUtah Medical Products has only been increasing its dividend for 1 years.Dividend CoverageThe dividend payout ratio of Utah Medical Products is 26.16%. This payout ratio is at a healthy, sustainable level, below 75%. Previous Next 4.1 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreUtah Medical Products has received a 57.02% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Blood pressure monitors" and "Surgical instruments" products. See details.Environmental SustainabilityThe Environmental Impact score for Utah Medical Products is -0.92. Previous Next 2.9 News and Social Media Coverage News SentimentUtah Medical Products has a news sentiment score of 1.23. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.66 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Utah Medical Products this week, compared to 0 articles on an average week. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Utah Medical Products insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 6.60% of the stock of Utah Medical Products is held by insiders.Percentage Held by Institutions70.04% of the stock of Utah Medical Products is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Utah Medical Products is 20.57, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 111.54.Price to Earnings Ratio vs. SectorThe P/E ratio of Utah Medical Products is 20.57, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 101.62.Price to Book Value per Share RatioUtah Medical Products has a P/B Ratio of 3.16. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Utah Medical Products (NASDAQ:UTMD) StockUtah Medical Products, Inc. engages in the manufacturing, developing, and marketing of disposable and reusable medical devices. It focuses on the healthcare of women and babies. Its products are used for blood pressure monitoring and blood collection, electrosurgery, gynecology, neonatal critical care, perinatology, and urology. The company was founded on April 21, 1978 and is headquartered in Midvale, UT.Read More Receive UTMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Utah Medical Products and its competitors with MarketBeat's FREE daily newsletter. Email Address UTMD Stock News HeadlinesMarch 26, 2023 | finance.yahoo.comUtah Medical Products, Inc.'s (NASDAQ:UTMD) Stock's On An Uptrend: Are Strong Financials Guiding The Market?March 25, 2023 | msn.comHow Utah Is Protecting Workers Without the Baggage of Unions | OpinionMarch 27, 2023 | Weiss Ratings (Ad)Urgent WarningThis was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …March 11, 2023 | finance.yahoo.comUtah Medical Products (NASDAQ:UTMD) Could Be A Buy For Its Upcoming DividendMarch 5, 2023 | finance.yahoo.comThe Returns On Capital At Utah Medical Products (NASDAQ:UTMD) Don't Inspire ConfidenceFebruary 10, 2023 | finance.yahoo.comUtah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.295February 7, 2023 | msn.comUtah Medical Products declares $0.295 dividendJanuary 31, 2023 | msn.comUtah Medical Products GAAP EPS of $1.25, revenue of $13.58MMarch 27, 2023 | Weiss Ratings (Ad)Urgent WarningThis was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …January 31, 2023 | finanznachrichten.deUtah Medical Products, Inc.: UTMD Reports Audited Year 2022 and Fourth Quarter Financial PerformanceJanuary 31, 2023 | finance.yahoo.comUTMD Reports Audited Year 2022 and Fourth Quarter Financial PerformanceJanuary 9, 2023 | finance.yahoo.comHere's Why We Think Utah Medical Products (NASDAQ:UTMD) Might Deserve Your Attention TodayDecember 26, 2022 | finance.yahoo.comUtah Medical Products, Inc. (NASDAQ:UTMD) is favoured by institutional owners who hold 65% of the companyDecember 11, 2022 | finance.yahoo.comUtah Medical Products (NASDAQ:UTMD) stock performs better than its underlying earnings growth over last five yearsDecember 6, 2022 | seekingalpha.comIs Utah Medical Products Suitable As A Defensive Overlay In Equity Portfolios?November 27, 2022 | finance.yahoo.comCalculating The Fair Value Of Utah Medical Products, Inc. (NASDAQ:UTMD)November 13, 2022 | finance.yahoo.comUtah Medical Products Third Quarter 2022 Earnings: EPS: US$1.18 (vs US$1.15 in 3Q 2021)November 1, 2022 | finance.yahoo.comUtah Medical Products, Inc. Increases Regular Quarterly DividendOctober 25, 2022 | finance.yahoo.comUTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2022October 17, 2022 | cnbc.comUtah's cookie war heats up in court – and on social mediaOctober 14, 2022 | seekingalpha.comUTMD Utah Medical Products, Inc.October 11, 2022 | msn.comCVS absorbs ‘menstrual tax’ in Utah and addresses period stigmaSeptember 26, 2022 | finance.yahoo.comReturn Trends At Utah Medical Products (NASDAQ:UTMD) Aren't AppealingAugust 31, 2022 | stocknews.comCathie Wood Is Building up Her Stake in This Stock. Should You?August 22, 2022 | reuters.comUtah Medical Products IncAugust 6, 2022 | finance.yahoo.comUtah Medical Products (NASDAQ:UTMD) Is Paying Out A Dividend Of $0.29July 28, 2022 | morningstar.comUtah Medical Products Inc - Stock NewsSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive UTMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Utah Medical Products and its competitors with MarketBeat's FREE daily newsletter. Email Address UTMD Company Calendar Ex-Dividend for 1/4 Dividend12/15/2022Dividend Payable1/04/2023Last Earnings1/31/2023Ex-Dividend for 4/4 Dividend3/16/2023Today3/27/2023Dividend Payable4/04/2023Next Earnings (Estimated)4/25/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryHealth Care Supplies SectorMedical Current SymbolNASDAQ:UTMD CUSIP91748810 CIK706698 Webwww.utahmed.com Phone(801) 566-1200Fax801-566-7305Employees178Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$4.51 Trailing P/E Ratio20.60 Forward P/E RatioN/A P/E GrowthN/ANet Income$16.47 million Net Margins31.51% Pretax Margin39.23% Return on Equity15.21% Return on Assets13.94% Debt Debt-to-Equity RatioN/A Current Ratio13.44 Quick Ratio12.11 Sales & Book Value Annual Sales$52.28 million Price / Sales6.45 Cash Flow$6.15 per share Price / Cash Flow15.10 Book Value$29.34 per share Price / Book3.17Miscellaneous Outstanding Shares3,630,000Free Float3,389,000Market Cap$337.19 million OptionableNot Optionable Beta0.16 Key ExecutivesKevin Leighton CornwellChairman, President, CEO & SecretaryBrian Lee KoopmanChief Financial Officer & ControllerPaul Olson RichinsIndependent DirectorKey CompetitorsAnika TherapeuticsNASDAQ:ANIKOraSure TechnologiesNASDAQ:OSURCerusNASDAQ:CERSAtrionNASDAQ:ATRITactile Systems TechnologyNASDAQ:TCMDView All CompetitorsInsiders & InstitutionsT. Rowe Price Investment Management Inc.Sold 271 shares on 2/15/2023Ownership: 9.419%Ancora Advisors LLCSold 1,508 shares on 2/15/2023Ownership: 0.626%Morgan StanleySold 428 shares on 2/15/2023Ownership: 0.257%Lazard Asset Management LLCBought 248 shares on 2/15/2023Ownership: 0.045%Charles Schwab Investment Management Inc.Bought 171 shares on 2/13/2023Ownership: 0.388%View All Insider TransactionsView All Institutional Transactions UTMD Stock - Frequently Asked Questions How have UTMD shares performed in 2023? Utah Medical Products' stock was trading at $100.53 at the start of the year. Since then, UTMD stock has decreased by 7.6% and is now trading at $92.89. View the best growth stocks for 2023 here. Are investors shorting Utah Medical Products? Utah Medical Products saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 32,600 shares, an increase of 22.6% from the February 28th total of 26,600 shares. Based on an average daily trading volume, of 10,600 shares, the days-to-cover ratio is currently 3.1 days. Currently, 1.0% of the shares of the stock are sold short. View Utah Medical Products' Short Interest. When is Utah Medical Products' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 25th 2023. View our UTMD earnings forecast. How were Utah Medical Products' earnings last quarter? Utah Medical Products, Inc. (NASDAQ:UTMD) issued its quarterly earnings data on Tuesday, January, 31st. The medical instruments supplier reported $1.25 earnings per share for the quarter. The medical instruments supplier earned $13.58 million during the quarter. Utah Medical Products had a trailing twelve-month return on equity of 15.21% and a net margin of 31.51%. How often does Utah Medical Products pay dividends? What is the dividend yield for Utah Medical Products? Utah Medical Products declared a quarterly dividend on Tuesday, February 7th. Investors of record on Friday, March 17th will be given a dividend of $0.295 per share on Tuesday, April 4th. This represents a $1.18 annualized dividend and a yield of 1.27%. The ex-dividend date of this dividend is Thursday, March 16th. Read our dividend analysis for UTMD. What ETFs hold Utah Medical Products' stock? ETFs with the largest weight of Utah Medical Products (NASDAQ:UTMD) stock in their portfolio include Royce Quant Small-Cap Quality Value ETF (SQLV). Is Utah Medical Products a good dividend stock? Utah Medical Products (NASDAQ:UTMD) pays an annual dividend of $1.18 per share and currently has a dividend yield of 1.27%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 26.16%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for UTMD. What is Kevin L. Cornwell's approval rating as Utah Medical Products' CEO? 8 employees have rated Utah Medical Products Chief Executive Officer Kevin L. Cornwell on Glassdoor.com. Kevin L. Cornwell has an approval rating of 43% among the company's employees. This puts Kevin L. Cornwell in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Utah Medical Products own? Based on aggregate information from My MarketBeat watchlists, some companies that other Utah Medical Products investors own include Simon Property Group (SPG), Walt Disney (DIS), UnitedHealth Group (UNH), Intuitive Surgical (ISRG), Altria Group (MO), SEI Investments (SEIC), Trupanion (TRUP), Visa (V), Ventas (VTR) and What is Utah Medical Products' stock symbol? Utah Medical Products trades on the NASDAQ under the ticker symbol "UTMD." Who are Utah Medical Products' major shareholders? Utah Medical Products' stock is owned by many different retail and institutional investors. Top institutional investors include T. Rowe Price Investment Management Inc. (9.42%), Renaissance Technologies LLC (5.80%), Dimensional Fund Advisors LP (4.23%), Rice Hall James & Associates LLC (3.15%), JPMorgan Chase & Co. (2.29%) and Geode Capital Management LLC (1.94%). Insiders that own company stock include Barbara A Payne, Barbara A Payne, Ernst G Hoyer, Kevin L Cornwell and Paul O Richins. View institutional ownership trends. How do I buy shares of Utah Medical Products? Shares of UTMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Utah Medical Products' stock price today? One share of UTMD stock can currently be purchased for approximately $92.89. How much money does Utah Medical Products make? Utah Medical Products (NASDAQ:UTMD) has a market capitalization of $337.19 million and generates $52.28 million in revenue each year. The medical instruments supplier earns $16.47 million in net income (profit) each year or $4.51 on an earnings per share basis. How many employees does Utah Medical Products have? The company employs 178 workers across the globe. How can I contact Utah Medical Products? Utah Medical Products' mailing address is 7043 South 300 West, Midvale UT, 84047. The official website for the company is www.utahmed.com. The medical instruments supplier can be reached via phone at (801) 566-1200 or via fax at 801-566-7305. This page (NASDAQ:UTMD) was last updated on 3/27/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.